TabsDetailsBasic DetailsDate Posted: Wednesday, May 20, 2020Status: CompleteMedical Product: antipsychotic, atypical antipsychotic, typical antipsychoticDescription: The objective of this request was to identify use of typical and atypical antipsychotics among neonates during inpatient encounters using Hospital Corporation of America (HCA) Healthcare data. HCA's Sentinel data (ETL 3.0) from July 1, 2011 - September 30, 2017 were included in this report. This request was distributed on August 15, 2019. Read More Deliverables (1)Sentinel Modular Program Report: Use of Typical and Atypical Antipsychotics Among InfantsAdditional InformationAdditional DetailsFDA Center: CDERTime Period: July 1, 2011 - September 30, 2017Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All children less than 180 days of ageData Sources: Sentinel Distributed Database (SDD)Related Links: 2020 ICPE Presentation: Antipsychotic Medication Use among Hospitalized Infants Using Inpatient Data in FDA’s Sentinel System
